ACRIVON THERAPEUTICS INC (ACRV) Earnings History & Surprises

NASDAQ:ACRV • US0048901096

Current stock price

1.6 USD
-0.06 (-3.61%)
At close:
1.6 USD
0 (0%)
After Hours:

ACRV Earnings overview

Past quarterly earnings results for ACRIVON THERAPEUTICS INC (ACRV), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).

Earnings Snapshot

Next Earnings Date

Upcoming
Release Date
Mar 26, 2026
Period
Q4 / 2025
EPS Estimate
-$0.48
Revenue Estimate
169.024K

Last Reported

Most Recent
Release Date
Nov 13, 2025
Period
Q3 / 2025
EPS Reported
-$0.47
EPS Surprise
21.90%
Revenue Surprise
%

Beat Rate

Last 8 Quarters
38%
EPS and Revenue beats vs estimates

Quarterly Earnings Historical Results

EPS & Revenue History (in USD): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.

QuarterEPSEPS EstEPS SurpriseEPS Q2QRevenueRevenue EstRevenue SurpriseRevenue Q2Q
Q3 2025 -0.47 -0.60 21.90% 20.34% - -
Q2 2025 -0.55 -0.60 8.02% -5.77% - -
Q1 2025 -0.51 -0.66 22.15% 30.14% - -
Q4 2024 -0.60 -0.68 11.91% 30.23% - -
Q3 2024 -0.59 -0.59 -0.13% 10.61% - -
Q2 2024 -0.52 -0.61 15.33% 17.46% - -
Q1 2024 -0.73 -0.86 15.28% -25.86% - -
Q4 2023 -0.86 -0.74 -15.99% -7.50% - -
Q3 2023 -0.66 -0.72 8.67% - - -
Q2 2023 -0.63 -0.66 4.77% - - -
Q1 2023 -0.58 -0.61 5.27% - - -
Q4 2022 -0.80 -1.12 28.37% - - -
Q3 2022 - - - -
Q2 2022 - - - -
Q4 2021 - - - -
Q2 2021 - - - -

Notes

  • EPS and Revenue values are non-GAAP when available, otherwise GAAP.
  • Surprise % is (Actual - Estimate) / |Estimate|. Green indicates positive surprise, red negative.
  • Q2Q % is quarter-over-quarter growth. Green indicates growth, red indicates decline.
  • Green right border indicates acceleration for sales or earnings growth. Acceleration is the case when the current Q2Q is above the previous Q2Q.

Earnings Q2Q Performance Trends

EPS Historical Q2Q growth and Acceleration

ACRV EPS Q2Q GrowthACRV EPS Q2Q GrowthEPS Q2Q Growth Q4/23 Q1/24 Q2/24 Q3/24 Q4/24 Q1/25 Q2/25 Q3/25 Q4/25 Q1/26 Q2/26 Q3/26 Q4/26 0 10 -10 20 -20 30

Revenue Historical Q2Q growth and Acceleration

ACRV Revenue Q2Q GrowthACRV Revenue Q2Q GrowthRevenue Q2Q Growth Q4/26 -20 -40 -60 -80

Surprise distribution (Last 4 Quarters)

EPS beat statistics

EPS beat (4)
4
Average EPS beat (4)
16.00%
Max EPS beat (4)
22.15%
Min EPS beat (4)
8.02%

Revenue beat statistics

Revenue beat (4)
N/A
Average Revenue beat (4)
N/A
Max Revenue beat (4)
N/A
Min Revenue beat (4)
N/A

Analysis

In the last 4 quarters, ACRV has consistently beaten EPS estimates in all releases
In the last 4 quarters, ACRV has beaten the EPS estimates by 16.0% on average.
ACRV Overview ACRV Technical Analysis Report ACRV Fundamental Analysis Report ACRV Forecast & Price Target
→ Find peers who consistently beat earnings by at least 10% in the last 4 quarters

ACRIVON THERAPEUTICS INC / ACRV Earnings FAQ

Can you provide the last earnings date for ACRIVON THERAPEUTICS INC?

ACRIVON THERAPEUTICS INC (ACRV) last reported earnings on 11/13/2025.

Did ACRIVON THERAPEUTICS INC (ACRV) beat earnings estimates last quarter?

ACRIVON THERAPEUTICS INC (ACRV) beat EPS estimates and missed revenue estimates in the most recent quarter.

Can you provide information on how often ACRIVON THERAPEUTICS INC beats earnings estimates?

In the last 4 quarters, ACRIVON THERAPEUTICS INC (ACRV) has beaten EPS estimates in 4 out of 4 releases.